Divisadero Street Capital Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.4M Sell
800,931
-359,024
-31% -$10.1M 0.51% 42
2026
Q1
$33.1M Buy
+1,159,955
New +$39.6M 1.38% 23
2025
Q4
Sell
-5,959
Closed -$210K 101
2025
Q3
$210K Sell
5,959
-27,731
-82% -$955K 0.01% 157
2025
Q2
$1.1M Hold
33,690
0.07% 100
2025
Q1
$1.09M Sell
33,690
-179,292
-84% -$6.66M 0.11% 69
2024
Q4
$6.51M Sell
212,982
-1,082,724
-84% -$34.8M 0.76% 32
2024
Q3
$36.3M Buy
+1,295,706
New +$31.9M 4.41% 10

Other funds holding ATRC

Divisadero Street Capital Management's ATRC Position: Q2 2026 in Review

Divisadero Street Capital Management reduced its AtriCure (ATRC) stake by 31% in Q2 2026, selling an estimated $10.1M and leaving 800,931 shares worth $22.4M. The position accounts for 0.51% of the portfolio, ranked #42.

Divisadero Street Capital Management first reported a position in ATRC in Q3 2024 and has held it in 7 quarters since. The position peaked at $36.3M in Q3 2024. 252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Divisadero Street Capital Management held 800,931 shares of AtriCure worth $22.4M as of Q2 2026.
  • Divisadero Street Capital Management sold 359,024 AtriCure shares in Q2 2026, an estimated $10.1M.
  • AtriCure made up 0.51% of Divisadero Street Capital Management's portfolio in Q2 2026, its #42 holding.
  • Divisadero Street Capital Management first reported a position in AtriCure in Q3 2024 and has held it in 7 quarters since.
  • Divisadero Street Capital Management's AtriCure position peaked at $36.3M in Q3 2024.
  • 252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Divisadero Street Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.